Medicine and Dentistry
Cell Transdifferentiation
100%
Beta Cell
91%
Diabetes
75%
Streptozocin
74%
Pancreatic Islet
50%
Glucagon
45%
Glucagon Like Peptide 1
40%
Hydrocortisone
32%
Exenatide
31%
Diabetic Obesity
28%
Glucagon Like Peptide 1 Receptor
25%
Incretin
22%
Antidiabetic Activity
22%
Programmed Cell Death
21%
Antidiabetic Agent
21%
Gut
21%
Insulin Resistance
20%
Receptor
17%
Gastric Inhibitory Polypeptide
16%
Dapagliflozin
16%
Sitagliptin
16%
Food Intake
15%
Drug Therapy
14%
Glucagon-Like Peptide-1 Agonist
14%
Vasopressin V1a Receptor
14%
Vasopressin V1b Receptor
14%
Metabolism
14%
Pancreas Polypeptide
14%
Apelin
14%
Adjuvant Therapy
14%
Low Drug Dose
14%
Body Weight
10%
Cell Differentiation
10%
Diabetes Mellitus
9%
Transcription Factors
9%
Cell Proliferation
9%
Fat Intake
8%
Cell Growth
8%
Combination Therapy
7%
Endocrine Cell
7%
Bariatric Surgery
7%
Drug Megadose
7%
Glucose Tolerance
7%
Cell Lineage
6%
Caloric Intake
6%
Hyperglycemia
6%
Blood Glucose
6%
Cell Loss
6%
Therapeutic Procedure
5%
Metabolic Regulation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
78%
Exendin 4
43%
Streptozotocin
41%
Glucagon-Like Peptide-1
38%
Receptor
32%
Glucagon
30%
Tarantula
28%
Antidiabetic Agent
28%
Incretin
21%
Liraglutide
16%
Dapagliflozin
16%
Peptide YY
16%
Glucagon Like Peptide 1 Receptor Agonist
14%
Receptor Agonist
14%
Pharmacotherapy
14%
Oxyntomodulin
14%
Cholecystokinin Receptor
14%
Apelin
14%
Glucagon Receptor Antagonist
14%
Neuropeptide
14%
Diabetes Mellitus
11%
Glucagon-Like Peptide 1 Receptor
10%
Cholecystokinin A Receptor
10%
Combination Therapy
9%
Carboxamide
8%
Hydrocortisone
8%
Sodium Glucose Cotransporter
8%
Drug Development
7%
Insulin Deficiency
5%
Amino Acid
5%
Biochemistry, Genetics and Molecular Biology
Mouse
79%
Glucagon
35%
Neuropeptide
33%
Transdifferentiation
31%
Streptozotocin
30%
Pancreatic Polypeptide
28%
Peptide YY
28%
Petromyzon
25%
Cell Growth
19%
Liraglutide
16%
Receptor Antagonist
14%
Glucagon Receptor
14%
Cholecystokinin Receptor
14%
Agonist
14%
Gastric Inhibitory Polypeptide
14%
Receptor Agonists
14%
Enteroglucagon
14%
Low Drug Dose
13%
Cholecystokinin A Receptor
10%
Insulin Release
7%
Body Weight
7%
Drug Megadose
7%
Insulin Blood Level
5%
Liquid
5%